Yang S. Choi
Suwon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Corrigendum to "A peptide derived from the core β-sheet region of TIRAP decoys TLR4 and reduces inflammatory and autoimmune symptoms in murine models" [eBioMedicine 52 (2020) 102645].
Journal: EBioMedicine
Published: October 30, 2025
Discovery of ETI41 and ETI60: novel selective endosomal Toll-like receptor inhibitors for the treatment of autoimmune diseases.
Journal: Experimental & molecular medicine
Published: December 03, 2024
Discovery of Novel Small Molecule Dual Inhibitor Targeting Toll-Like Receptors 7 and 9.
Journal: Journal of chemical information and modeling
Published: June 21, 2024
Toll-Like Receptor Blockage by TIP-1 and MIP-2 Treatment Mitigates Inflammation in a Mouse Model of Adult-Onset Still's Disease or Still's Disease.
Journal: European journal of immunology
Published: April 30, 2024
Hyaluronic Acid Nanoparticles as a Topical Agent for Treating Psoriasis.
Journal: ACS nano
Published: November 14, 2022
Changes in Shoulder Trauma during the COVID-19 Pandemic: A South Korean Survey.
Journal: Clinics in orthopedic surgery
Published: April 06, 2022
The αC helix of TIRAP holds therapeutic potential in TLR-mediated autoimmune diseases.
Journal: Biomaterials
Published: July 13, 2019
A peptide derived from the core β-sheet region of TIRAP decoys TLR4 and reduces inflammatory and autoimmune symptoms in murine models.
Journal: EBioMedicine
Published: May 03, 2019
Proteomic profiling of serum from patients with tuberculosis.
Journal: Annals of laboratory medicine
Published: November 08, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026